Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Neurol Neurosurg ; 108(3): 271-4, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16378679

RESUMEN

Effective therapy in the earliest stages of multiple sclerosis (MS) demands early correct diagnosis. Retrospective analysis included 130 patients (90 women) with a median age of 35.5 years, median duration of the disease of 2 years and median EDSS score of 3.0. Twenty-seven patients had clinically isolated syndrome (CIS) suggestive of MS, 66 relapsing-remitting (RR) MS, 19 secondary progressive (SP) MS and 18 primary progressive (PP) MS. The predominant symptoms were sensory in 52% of the patients with CIS compared to 27% in patients with RRMS, whereas they were more often motor in patients with PPMS. Patients with CIS had higher CSF cell counts than patients diagnosed in later stages of the disease and oligoclonal bands were found in 89% of all patients without statistically significant differences between the subgroups. Prolonged latencies of visual evoked potentials (VEP) were found in only 29% of patients with CIS compared to 66% in RRMS, 75% in SPMS and 65% of PPMS patients. Fifty-six percent of patients with CIS, 88% with RRMS, 74% with SPMS and 78% of patients with PPMS fulfilled modified the Barkhof et al. MRI criteria at the time of diagnosis. Patients in early MS often present with sensory symptoms. Brain MRI can be inconclusive in over 40% of patients with CIS but the elevated CSF cell count and positive oligoclonal bands are helpful in establishing the diagnosis of CIS suggestive of MS. In later stages of the disease the combination of clinical features, MRI, prolonged VEP latencies and positive CSF oligoclonal bands secures the correct diagnosis.


Asunto(s)
Encéfalo/patología , Proteínas del Líquido Cefalorraquídeo/líquido cefalorraquídeo , Potenciales Evocados/fisiología , Inmunoglobulina G/líquido cefalorraquídeo , Esclerosis Múltiple , Médula Espinal/patología , Adolescente , Adulto , Anciano , Femenino , Humanos , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Esclerosis Múltiple/metabolismo , Esclerosis Múltiple/patología , Esclerosis Múltiple/fisiopatología
2.
Clin Neurol Neurosurg ; 106(3): 255-8, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15177779

RESUMEN

Multiple sclerosis is characterized by elevated levels of proinflammatory cytokines produced by Th1 cells and decreased levels of anti-inflammatory cytokines produced by Th2 cells. IFN-beta treatment shifts the immune response from the Th1 to Th2 pattern, thus enhancing the production of anti-inflammatory Th2 cytokines such as IL-4, IL-10, and decreasing the production of proinflammatory Th1 cytokines such as IFN-gamma. To determine which IFN-beta has the stronger immunomodulatory effect we compared the levels of IL-4, IL-10, and IFN-gamma of 12 relapsing-remiting MS patients treated with IFN-beta1b (Betaferon) with those of 10 patients treated with IFN-beta1a (Avonex). There were no statistically significant differences in duration of disease, number of relapses before and during treatment, and in EDSS after 2 years of treatment. After 1 year of treatment the concentration of IFN-gamma was significantly lower in the Betaferon group, and concentrations of IL-4 and IL-10 were significantly higher in the Avonex group. It appears that IFN-beta1b has a downregulatory effect on both Th1 and Th2 cytokines, while IFN-beta1a causes a shift of the cytokine profile toward the Th2 phenotype. These two IFN have different influences on the pattern of cytokines in MS: IFN-beta1a enhances the production of anti-inflammatory cytokines IL-4 and IL-10 and IFN-beta1b decreases the production of the proinflammatory cytokine IFN-gamma.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Adyuvantes Inmunológicos/uso terapéutico , Interferón beta/farmacología , Interferón beta/uso terapéutico , Esclerosis Múltiple Recurrente-Remitente/tratamiento farmacológico , Adyuvantes Inmunológicos/administración & dosificación , Adolescente , Adulto , Esquema de Medicación , Femenino , Humanos , Inyecciones Subcutáneas , Interferón beta-1a , Interferon beta-1b , Interferón beta/administración & dosificación , Interferón gamma/inmunología , Interferón gamma/metabolismo , Interleucina-10/inmunología , Interleucina-10/metabolismo , Interleucina-4/inmunología , Interleucina-4/metabolismo , Masculino , Persona de Mediana Edad , Esclerosis Múltiple Recurrente-Remitente/inmunología , Células TH1/inmunología , Células TH1/metabolismo , Células Th2/inmunología , Células Th2/metabolismo
3.
Croat Med J ; 44(6): 697-701, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14652881

RESUMEN

AIM: To determine the frequency and clinical and laboratory features of patients with multiple sclerosis characterized by uncommon cerebrospinal findings, ie, negative oligoclonal band or increased number of mononuclear cells in cerebrospinal fluid. METHODS: The retrospective analysis included medical records of 233 patients (158 women and 75 men) admitted to the Department of Neurology, Ljubljana Medical Center, between January 1, 1990, and December 31, 1999 and discharged with the diagnosis of multiple sclerosis. We determined clinical features and cerebrospinal fluid parameters of patients with oligoclonal band-negative multiple sclerosis and > or =15 mononuclear cells/mm( 3) in cerebrospinal fluid and compared them with patients with oligoclonal band-positive multiple sclerosis and expected number of mononuclear cells in cerebrospinal fluid, respectively. There were 26 patients with oligoclonal band-negative finding and 26 with > or =15 mononuclear cells/mm(3) in cerebrospinal fluid. The two groups of patients did not overlap, except for one patient, who had 19 mononuclear cells/mm(3) and was oligoclonal band-negative. RESULTS: The diagnosis was delayed in oligoclonal band-negative multiple sclerosis patients, their cerebrospinal fluid contained less leukocytes, and lower concentration of IgG. The patients with > or =15 leukocytes/mm( 3) in cerebrospinal fluid were diagnosed earlier and had increased cerebrospinal fluid protein and IgG concentrations. CONCLUSION: Multiple sclerosis with negative oligoclonal band or increased count of leukocytes in cerebrospinal fluid were found in approximately 10% of patients with the disease. Because of the absence of oligoclonal band and less active cerebrospinal fluid, the diagnosis in these patients may be delayed.


Asunto(s)
Esclerosis Múltiple/líquido cefalorraquídeo , Esclerosis Múltiple/diagnóstico , Bandas Oligoclonales/líquido cefalorraquídeo , Adulto , Anciano , Femenino , Humanos , Leucocitos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
4.
Brain Lang ; 81(1-3): 242-9, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12081396

RESUMEN

The present study is concerned with two Slovenian-speaking patients who were asked to produce, in various tasks, verbs, nouns, and adjectives derived by prefixation with prepositions. Despite differences due to their specific linguistic difficulties, both patients' performance was characterized by the differential processing of prefixes and remaining components of complex words. Prepositions in prefixation were mostly preserved, and less frequently substituted, regardless of the numerous errors produced in the remaining portion of the words. These errors seem clearly determined by the morphological structure of the words and therefore appear to be authentic morphological errors. These findings contribute to the theoretical debate on mental lexical representation, speaking in favor of a morphological decomposition in processing of prefixed complex words at different processing levels.


Asunto(s)
Afasia de Broca/diagnóstico , Lingüística , Femenino , Humanos , Lenguaje , Persona de Mediana Edad , Pruebas Neuropsicológicas , Índice de Severidad de la Enfermedad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA